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the PTV in range of 95-115% of the prescribed dose. A DVH was 
exported for each plan to compare target coverage, conformity and 
homogeneity indexes.  
Results: Preliminary studies investigating the effect of protracting 
dose relative to acute delivery suggest that when 1000 cGy is 
delivered over 15+ minutes, cell survival may increase. This study was 
done, however, on a non-moving target prior to acquisition of the 
respiratory phantom. Consequently cells need to be irradiated in the 
moving phantom, and the dose calculation confirmed through OSLD 
dosimetry. The conformity index (CI95%) and PTV homogeneity index 
both decrease in gated as opposed to non-gated plans. The 
improvement in the CI95% and HI is shown to be dependent on the 
length of the duty cycle selected.  
Conclusions: Though dose optimizations result in very similar dose 
coverage for gated and non-gated plans, the irregularity of patient 
respiratory traces implies delivering a precise dose is difficult. This 
study will provide cell survival results and dosimetric data for three 
gated and a non-gated plan for 10 patient traces. 
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Purpose/Objective: To evaluate the impact of organ motion on dose 
distribution for conventional, 3DCRT (three-Dimensional Conformal 
Radiation Therapy), IMRT (Intensity Modulated Radiation Therapy) and 
VMAT (Volumetric Modulated Arc Therapy) gated and ungated 
treatments. 
Materials and Methods: A motion phantom (Quasar respiratory 
phantom, Modus Medical Devices) was used to simulate sinusoidal 
motion with peak-to-peak ‘breathing’ amplitude of 2cm and different 
frequencies (12 and 20 breaths/min), synchronized with Real-Time 
Positional Management (RPM) System (Varian Medical System, Palo 
Alto CA). Dose evaluations regarding static, ungated and gated 
delivery were carried out using EBT2 films. For all treatments a 6MV 
photon beam was used and 3Gy were prescribed and delivered to the 
isocenter. For conventional treatments we acquired dose profiles in 
motion direction for different gating windows. The profiles were 
compared to those obtained with the stationary phantom delivery in 
terms of displacements of therapeutic dose levels (95% prescribed 
dose) and low dose levels (20% prescribed dose). 3DCRT and IMRT 
treatments were performed in static, ungated and gated mode (40%-
70% phase at exhale) whereas VMAT was performed only in static and 
ungated mode, because this treatment technique is not managed by 
the accelerator Varian's Clinac DHX. Measured dose distributions in 
3DCRT, IMRT and VMAT treatments were compared to those planned 
using the gamma index with 3mm distance-to-agreement and 5% dose-
difference criteria.  
Results: As regards conventional treatment, ungated profiles 
displacements at the 95% and 20% dose levels were 12mm and 15mm 
respectively. Gated profiles showed an asymmetric enlargement 
according to target position with respect to the gating window: range 
shifts at the 95% and 20% dose levels were from 4 to 29mm and from 
8.5 to 25.6mm respectively. In static dose distributions the 
percentage of points passing the gamma criteria, for all treatments, 
was 92%. The dynamic measurements showed a gamma agreement of 
30-33% for all ungated treatments and of 70-74% for gated 3DCRT and 
IMRT delivery. Respiratory motion resulted in significant dose blurring, 
which led to an enlarged beam penumbra at the field edge and 
thereby underdosing of the target and overdosing of surrounding 
areas. This effect was reduced by gated delivery although dose 
distribution enlargement was still observed due to the residual motion 
inside the gating windows. 
Conclusions: The profile analysis in the conventional treatment 
suggests that dose blurring could be reduced by applying asymmetric 
expansion margins to the CTV according to gating window. 
Experimental evidence suggests that, if a significant organ motion is 
involved and a respiratory management system is not used, modulated 
intensity techniques should be avoided, because planned dose 
distribution is not longer representative of delivered dose.  
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Purpose/Objective: Prospective assessment of setup errors using 3D 
cone-beam CT (CBCT) and stereoscopic kV imaging using fiducial 
markers for image registration. 
Materials and Methods: 23 patients underwent prostate ± seminal 
vesicle radiotherapy with 3 fiducial markers (1/23 had 5 markers). 
Each patient was randomised to start treatment on one of 2 linacs 
with different imaging systems, one with OBI (linac 1), the other with 
ExacTrac (linac 2), and then alternate weekly. Only OBI imaging is 
considered here. Prior to each fraction on linac 1, a CBCT was 
acquired, followed immediately by a pair of orthogonal stereoscopic 
kV images (kV/kV) using Varian OBI (v1.4 & 1.5). kV images were 
automatically matched online using marker match software (including 
couch/yaw rotation), and translations applied prior to treatment. 318 
of 375 CBCTs acquired were available to match, and were matched 
offline – first to stable pelvic bony anatomy (for couch/yaw rotation) 
and then manually to an average position of all markers for the 
translations. Setup results were compared between CBCT and kV 
image matches in each orthogonal direction. The imaging methods 
were considered equivalent if the difference between setup errors 
were <2mm in each direction in 90% of cases.  
To aid comparison, patient population systematic and random errors 
were also calculated, and imaging isocentre coincidence (with 
mechanical linac isocentre) was obtained from analysis of regular QA 
results. 
Results: 207 of 318 fractions (65%) gave a difference in setup error 
<2mm in all directions. Average difference (CBCT – kV/kV) was 
0.3mm. Population systematic and random errors, and imaging 
isocentre accuracy are shown in table 1. 
 
(mm) Population 
systematic errors 
Population 
random errors 
Imaging isocentre 
coincidence with linac 
isocentre 
L/R S/I A/P L/R S/I A/P L/R S/I A/P 3D 
kV/kV 2.0 2.1 4.9 2.5 2.8 3.3 -0.1 ± 
0.4 
-0.1 ±
0.4 
0.6 ± 
0.5 
0.9 ± 
0.4 
CBCT 1.9 2.1 5.2 2.4 2.7 3.2 0.2 ± 
0.4 
0.3 ±
0.4 
0.4 ± 
0.5 
0.8 ± 
0.4 
 
Table 1: Population systematic and random setup errors, and 
isocentre accuracy for orthogonal kV, and CBCT imaging. Results are 
expressed in orthogonal patient axes: left/right (L/R), 
superior/inferior (S/I) and anterior/posterior (A/P). 
Conclusions: 35% of fractions showed setup error differences ≥2mm 
between orthogonal kV and CBCT that could be due to the subjective 
nature of the manual CBCT matching, and may be affected by the 
different matching methods used for couch rotation. In terms of 
isocentre accuracy and patient population random and systematic 
errors, CBCT and orthogonal kV modes showed similar results. If the 
same method for matching CBCTs offline can be performed online, 
this gives the flexibility to choose between setup using CBCT or 
orthogonal kV imaging without losing setup accuracy – depending on 
preference of gaining additional soft tissue information or faster setup 
with lower imaging dose. 
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Purpose/Objective: We report the results of motion management 
during gated rapidarc treatment using implanted fiducial markers and 
a novel application, Intrafraction Motion Review (IMR, Varian medical 
systems) allowing simultaneous KV/MV utilization. 
Materials and Methods: Eight liver cancer patients with implanted 
fiducial markers were treated using the gated RapidArc technique 
with a Varian Novalis Truebeam linear accelerator. The fiducial 
markers (1 to 3) were implanted inside or close to the tumor target 
before treatment simulation. For patient simulation, three to four 4D 
computed tomography (CT) scans were acquired using Real time 
Position management (RPM) system to study the reproducibility of 
liver motion. During the treatment planning, the internal target 
volume (ITV) was outlined. The PTV was created by adding a 5 mm 
margin from the ITV. In the same stage, the fiducial were marked in 
